Diagnosis and management of fetal growth restriction: the role of fetal therapy

Best Practice and Research in Clinical Obstetrics and Gynaecology

Volumn 22, Issue 1, 2008, Pages 139-158

  Hui, Lisa ^a   Challis, Daniel ^a  

^a ROYAL HOSPITAL FOR WOMEN   (Australia)

Author keywords

ductus venosus; fetal growth retardation; fetal monitoring; small for gestational age; ultrasonography, prenatal; umbilical arteries

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; ALPHA TOCOPHEROL; ANTIOXIDANT; ANTITHROMBOCYTIC AGENT; ANTIVIRUS AGENT; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CYTOMEGALOVIRUS VACCINE; HEPARIN; OXYGEN; PLACEBO; SOMATOMEDIN C; SPIRAMYCIN; SULFONAMIDE;

AMNION FLUID ANALYSIS; BED REST; CARDIOTOCOGRAPHY; CLINICAL TRIAL; CONGENITAL INFECTION; CONGENITAL TOXOPLASMOSIS; CYTOMEGALOVIRUS INFECTION; DELIVERY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIET THERAPY; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; DUCTUS VENOSUS; FETUS ECHOGRAPHY; FETUS GROWTH; FETUS RISK; GENITAL HERPES; GESTATIONAL AGE; HUMAN; INCIDENCE; INTRAUTERINE GROWTH RETARDATION; MIDDLE CEREBRAL ARTERY; NONHUMAN; NUTRITIONAL COUNSELING; OXIDATIVE STRESS; OXYGEN THERAPY; PATHOPHYSIOLOGY; PERINATAL MORBIDITY; PERINATAL MORTALITY; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PRENATAL DIAGNOSIS; PRIMARY PREVENTION; PRIORITY JOURNAL; REPEATED DRUG DOSE; RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SMALL FOR DATE INFANT; SMOKING CESSATION; SOCIAL SUPPORT; SYSTEMATIC REVIEW; THROMBOPHILIA; UMBILICAL ARTERY; VITAMIN SUPPLEMENTATION;

DELIVERY, OBSTETRIC; FEMALE; FETAL GROWTH RETARDATION; FETAL THERAPIES; HUMANS; PLACENTAL INSUFFICIENCY; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE; RISK FACTORS; ULTRASONOGRAPHY, PRENATAL;

EID: 39049124629     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2007.06.004     Document Type: Review

References (106)

1. Scott K.E., and Usher R. Fetal malnutrition: its incidence, causes, and effects. Am J Obstet Gynecol 94 7 (1966 Apr 1) 951-963
2. Kamoji V.M., Dorling J.S., Manktelow B.N., et al. Extremely growth-retarded infants: is there a viability centile?. Pediatrics 118 2 (2006 Aug) 758-763
3. Zelop C.M., Richardson D.K., and Heffner L.J. Outcomes of severely abnormal umbilical artery doppler velocimetry in structurally normal singleton fetuses. Obstet Gynecol 87 3 (1996 Mar) 434-438
4. McIntire D.D., Bloom S.L., Casey B.M., et al. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med 340 16 (1999 Apr 22) 1234-1238
5. Fang S. Management of preterm infants with intrauterine growth restriction. Early Hum Dev 81 11 (2005 Nov) 889-900
6. Garite T.J., Clark R., and Thorp J.A. Intrauterine growth restriction increases morbidity and mortality among premature neonates. Am J Obstet Gynecol 191 2 (2004 Aug) 481-487
7. Levy-Marchal C., and Jaquet D. Long-term metabolic consequences of being born small for gestational age. Pediatr Diabetes 5 3 (2004 Sep) 147-153
8. St Clair D., Xu M., Wang P., et al. Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. JAMA 294 5 (2005 Aug 3) 557-562
9. Chang T.C., Robson S.C., Boys R.J., et al. Prediction of the small for gestational age infant: which ultrasonic measurement is best?. Obstet Gynecol 80 6 (1992 Dec) 1030-1038
10. Brooke O.G., Anderson H.R., Bland J.M., et al. Effects on birth weight of smoking, alcohol, caffeine, socioeconomic factors, and psychosocial stress. BMJ 298 6676 (1989 Mar 25) 795-801
11. Spinillo A., Capuzzo E., Piazzi G., et al. Maternal high-risk factors and severity of growth deficit in small for gestational age infants. Early Hum Dev 38 1 (1994 Jul) 35-43
12. Campbell S., Warsof S.L., Little D., et al. Routine ultrasound screening for the prediction of gestational age. Obstet Gynecol 65 5 (1985 May) 613-620
13. Chervenak F.A., Skupski D.W., Romero R., et al. How accurate is fetal biometry in the assessment of fetal age?. Am J Obstet Gynecol 178 4 (1998 Apr) 678-687
14. Persson B., Stangenberg M., Lunell N.O., et al. Prediction of size of infants at birth by measurement of symphysis fundus height. Br J Obstet Gynaecol 93 3 (1986 Mar) 206-211
15. Belizan J.M., Villar J., Nardin J.C., et al. Diagnosis of intrauterine growth retardation by a simple clinical method: measurement of uterine height. Am J Obstet Gynecol 131 6 (1978 Jul 15) 643-646
16. Rosenberg K., Grant J.M., Tweedie I., et al. Measurement of fundal height as a screening test for fetal growth retardation. Br J Obstet Gynaecol 89 6 (1982 Jun) 447-450
17. Neilson J.P. Symphysis-fundal height measurement in pregnancy. Cochrane Database Syst Rev 2 (2000) CD000944
18. Bricker L., and Neilson J.P. Routine ultrasound in late pregnancy (after 24 weeks gestation). Cochrane Database Syst Rev 2 (2000) CD001451
19. Gardosi J., Mongelli M., Wilcox M., et al. An adjustable fetal weight standard. Ultrasound Obstet Gynecol 6 3 (1995 Sep) 168-174
20. McCowan L.M., Harding J.E., and Stewart A.W. Customized birthweight centiles predict SGA pregnancies with perinatal morbidity. BJOG 112 8 (2005 Aug) 1026-1033
21. de Jong C.L., Gardosi J., Dekker G.A., et al. Application of a customised birthweight standard in the assessment of perinatal outcome in a high risk population. Br J Obstet Gynaecol 105 5 (1998 May) 531-535
22. Clausson B., Gardosi J., Francis A., et al. Perinatal outcome in SGA births defined by customised versus population-based birthweight standards. BJOG 108 8 (2001 Aug) 830-834
23. Royal College of Obstetricians and Gynaecologists. The Investigation and Management of the Small-for-gestational-age fetus. RCOG Guideline No 31. 2002.
24. de Jong C.L., Francis A., van Geijn H.P., et al. Fetal growth rate and adverse perinatal events. Ultrasound Obstet Gynecol 13 2 (1999 Feb) 86-89
25. Mongelli M., Ek S., and Tambyrajia R. Screening for fetal growth restriction: a mathematical model of the effect of time interval and ultrasound error. Obstet Gynecol 92 6 (1998 Dec) 908-912
26. Snijders R.J., Sherrod C., Gosden C.M., et al. Fetal growth retardation: associated malformations and chromosomal abnormalities. Am J Obstet Gynecol 168 2 (1993 Feb) 547-555
27. Khan N.A., and Kazzi S.N. Yield and costs of screening growth-retarded infants for torch infections. Am J Perinatol 17 3 (2000) 131-135
28. Baschat A.A., and Hecher K. Fetal growth restriction due to placental disease. Semin Perinatol 28 1 (2004 Feb) 67-80
29. Weiner C.P. The relationship between the umbilical artery systolic/diastolic ratio and umbilical blood gas measurements in specimens obtained by cordocentesis. Am J Obstet Gynecol 162 5 (1990 May) 1198-1202
30. Nicolaides K.H., Bilardo C.M., Soothill P.W., et al. Absence of end diastolic frequencies in umbilical artery: a sign of fetal hypoxia and acidosis. BMJ 297 6655 (1988 Oct 22) 1026-1027
31. Karsdorp V.H., van Vugt J.M., van Geijn H.P., et al. Clinical significance of absent or reversed end diastolic velocity waveforms in umbilical artery. Lancet 344 8938 (1994 Dec 17) 1664-1668
32. Baschat A.A., and Weiner C.P. Umbilical artery doppler screening for detection of the small fetus in need of antepartum surveillance. Am J Obstet Gynecol 182 1 Pt 1 (2000 Jan) 154-158
33. Arabin B., Mohnhaupt A., Becker R., et al. Comparison of the prognostic value of pulsed Doppler blood flow parameters to predict SGA and fetal distress. Ultrasound Obstet Gynecol 2 4 (1992 Jul 1) 272-278
34. Soothill P.W., Ajayi R.A., Campbell S., et al. Prediction of morbidity in small and normally grown fetuses by fetal heart rate variability, biophysical profile score and umbilical artery Doppler studies. Br J Obstet Gynaecol 100 8 (1993 Aug) 742-745
35. Alfirevic Z., and Neilson J.P. Doppler ultrasonography in high-risk pregnancies: systematic review with meta-analysis. Am J Obstet Gynecol 172 5 (1995 May) 1379-1387
36. Bricker L., and Neilson J.P. Routine doppler ultrasound in pregnancy. Cochrane Database Syst Rev 2 (2000) CD001450
37. Nienhuis S.J., Vles J.S., Gerver W.J., et al. Doppler ultrasonography in suspected intrauterine growth retardation: a randomized clinical trial. Ultrasound Obstet Gynecol 9 1 (1997 Jan) 6-13
38. McCowan L.M., Harding J.E., Roberts A.B., et al. A pilot randomized controlled trial of two regimens of fetal surveillance for small-for-gestational-age fetuses with normal results of umbilical artery doppler velocimetry. Am J Obstet Gynecol 182 1 Pt 1 (2000 Jan) 81-86
39. Arduini D., Rizzo G., and Romanini C. Changes of pulsatility index from fetal vessels preceding the onset of late decelerations in growth-retarded fetuses. Obstet Gynecol 79 4 (1992 Apr) 605-610
40. Francisco R.P., Miyadahira S., and Zugaib M. Predicting pH at birth in absent or reversed end-diastolic velocity in the umbilical arteries. Obstet Gynecol 107 5 (2006 May) 1042-1048
41. Carvalho F.H., Moron A.F., Mattar R., et al. Ductus venosus Doppler velocimetry in the prediction of acidemia at birth: which is the best parameter?. Prenat Diagn 25 13 (2005 Dec) 1212-1216
42. Rizzo G., Capponi A., Talone P.E., et al. Doppler indices from inferior vena cava and ductus venosus in predicting pH and oxygen tension in umbilical blood at cordocentesis in growth-retarded fetuses. Ultrasound Obstet Gynecol 7 6 (1996 Jun) 401-410
43. Goncalves L., Romero R., Silva M., et al. Reverse flow in the ductus venosus: an ominous sign. Am J Obstet Gynecol (1995) 172
44. Ozcan T., Sbracia M., d'Ancona R.L., et al. Arterial and venous Doppler velocimetry in the severely growth-restricted fetus and associations with adverse perinatal outcome. Ultrasound Obstet Gynecol 12 1 (1998 Jul) 39-44
45. Hecher K., Campbell S., Doyle P., et al. Assessment of fetal compromise by Doppler ultrasound investigation of the fetal circulation. Arterial, intracardiac, and venous blood flow velocity studies. Circulation 91 1 (1995 Jan 1) 129-138
46. Schwarze A., Gembruch U., Krapp M., et al. Qualitative venous Doppler flow waveform analysis in preterm intrauterine growth-restricted fetuses with ARED flow in the umbilical artery-correlation with short-term outcome. Ultrasound Obstet Gynecol 25 6 (2005 Jun) 573-579
47. Baschat A.A., Gembruch U., Weiner C.P., et al. Qualitative venous Doppler waveform analysis improves prediction of critical perinatal outcomes in premature growth-restricted fetuses. Ultrasound Obstet Gynecol 22 3 (2003 Sep) 240-245
48. Pattison N., and McCowan L. Cardiotocography for antepartum fetal assessment. Cochrane Database Syst Rev 2 (2000) CD001068
49. Nielsen P.V., Stigsby B., Nickelsen C., et al. Computer assessment of the intrapartum cardiotocogram. II. The value of compared with visual assessment. Acta Obstet Gynecol Scand 67 5 (1988) 461-464
50. Anceschi M.M., Ruozi-Berretta A., Piazze J.J., et al. Computerized cardiotocography in the management of intrauterine growth restriction associated with Doppler velocimetry alterations. Int J Gynaecol Obstet 86 3 (2004 Sep) 365-370
51. Bastide A., Manning F., Harman C., et al. Ultrasound evaluation of amniotic fluid: outcome of pregnancies with severe oligohydramnios. Am J Obstet Gynecol 154 4 (1986 Apr) 895-900
52. Chamberlain P.F., Manning F.A., Morrison I., et al. Ultrasound evaluation of amniotic fluid volume. I. The relationship of marginal and decreased amniotic fluid volumes to perinatal outcome. Am J Obstet Gynecol 150 3 (1984 Oct 1) 245-249
53. Chauhan S.P., Sanderson M., Hendrix N.W., et al. Perinatal outcome and amniotic fluid index in the antepartum and intrapartum periods: a meta-analysis. Am J Obstet Gynecol 181 6 (1999 Dec) 1473-1478
54. Alfirevic Z., and Neilson J.P. Biophysical profile for fetal assessment in high risk pregnancies. Cochrane Database Syst Rev 2 (2000) CD000038
55. Manning F.A. The fetal biophysical profile score: current status. Obstet Gynecol Clin North Am 17 1 (1990 Mar) 147-162
56. Manning F.A., Harman C.R., Morrison I., et al. An analysis of perinatal morbidity and mortality. Am J Obstet Gynecol 162 3 (1990 Mar) 703-709
57. Dayal A.K., Manning F.A., Berck D.J., et al. Fetal death after normal biophysical profile score: An eighteen-year experience. Am J Obstet Gynecol 181 5 Pt 1 (1999 Nov) 1231-1236
58. Ferrazzi E., Bozzo M., Rigano S., et al. Temporal sequence of abnormal Doppler changes in the peripheral and central circulatory systems of the severely growth-restricted fetus. Ultrasound Obstet Gynecol 19 2 (2002 Feb) 140-146
59. Hecher K., Bilardo C.M., Stigter R.H., et al. Monitoring of fetuses with intrauterine growth restriction: a longitudinal study. Ultrasound Obstet Gynecol 18 6 (2001 Dec) 564-570
60. Baschat A.A., Gembruch U., and Harman C.R. The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens. Ultrasound Obstet Gynecol 18 6 (2001 Dec) 571-577
61. A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation. BJOG 110 1 (2003 Jan) 27-32
62. Thornton J.G., Hornbuckle J., Vail A., et al. Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet 364 9433 (2004 Aug 7-13) 513-520
63. Roberts D., and Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 3 (2006) CD004454
64. Crowther C.A., Haslam R.R., Hiller J.E., et al. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Lancet 367 9526 (2006 Jun 10) 1913-1919
65. Newnham J.P., Evans S.F., Godfrey M., et al. Maternal, but not fetal, administration of corticosteroids restricts fetal growth. J Matern Fetal Med 8 3 (1999 May-Jun) 81-87
66. French N.P., Hagan R., Evans S.F., et al. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 180 1 Pt 1 (1999 Jan) 114-121
67. Bloom S.L., Sheffield J.S., McIntire D.D., et al. Antenatal dexamethasone and decreased birth weight. Obstet Gynecol 97 4 (2001 Apr) 485-490
68. Banks B.A., Cnaan A., Morgan M.A., et al. Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group. Am J Obstet Gynecol 181 3 (1999 Sep) 709-717
69. Bernstein I.M., Horbar J.D., Badger G.J., et al. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network. Am J Obstet Gynecol 182 1 Pt 1 (2000 Jan) 198-206
70. Williams K.P., and Nwebube N. Abdominal circumference: a single measurement versus growth rate in the prediction of intrapartum Cesarean section for fetal distress. Ultrasound Obstet Gynecol 17 6 (2001 Jun) 493-495
71. Ben-Haroush A., Yogev Y., Glickman H., et al. Mode of delivery in pregnancies with suspected fetal growth restriction following induction of labor with vaginal prostaglandin E2. Acta Obstet Gynecol Scand 83 1 (2004 Jan) 52-57
72. Li H., Gudmundsson S., and Olofsson P. Prospect for vaginal delivery of growth restricted fetuses with abnormal umbilical artery blood flow. Acta Obstet Gynecol Scand 82 9 (2003 Sep) 828-833
73. Lee H.C., and Gould J.B. Survival rates and mode of delivery for vertex preterm neonates according to small- or appropriate-for-gestational-age status. Pediatrics 118 6 (2006 Dec) e1836-e1844
74. Baschat A.A., Bilardo C.M., Germer U., et al. Intervention thresholds for severe early onset growth restriction (IUGR). Ultrasound Obstet Gynecol 26 (2005) 353
75. Stevens-Simon C., and Orleans M. Low-birthweight prevention programs: the enigma of failure. Birth 26 3 (1999 Sep) 184-191
76. Lu M.C., Tache V., Alexander G.R., et al. Preventing low birth weight: is prenatal care the answer?. J Matern Fetal Neonatal Med 13 6 (2003 Jun) 362-380
77. Lumley J., Oliver S.S., Chamberlain C., et al. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 4 (2004) CD001055
78. Dolan-Mullen P., Ramirez G., and Groff J.Y. A meta-analysis of randomized trials of prenatal smoking cessation interventions. Am J Obstet Gynecol 171 5 (1994 Nov) 1328-1334
79. Papageorghiou A.T., Yu C.K., and Nicolaides K.H. The role of uterine artery Doppler in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 18 3 (2004 Jun) 383-396
80. Schwarze A., Nelles I., Krapp M., et al. Doppler ultrasound of the uterine artery in the prediction of severe complications during low-risk pregnancies. Arch Gynecol Obstet 271 1 (2005 Jan) 46-52
81. Axt-Fliedner R., Schwarze A., Nelles I., et al. The value of uterine artery Doppler ultrasound in the prediction of severe complications in a risk population. Arch Gynecol Obstet 271 1 (2005 Jan) 53-58
82. Papageorghiou A.T., Yu C.K., Bindra R., et al. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 18 5 (2001 Nov) 441-449
83. Elsandabesee D., Srinivas M., and Kodakkattil S. The clinical value of combining maternal serum screening and uterine artery Doppler in prediction of adverse pregnancy outcome. J Obstet Gynaecol 26 2 (2006 Feb) 115-117
84. Onalan R., Onalan G., Gunenc Z., et al. Combining 2nd-trimester maternal serum homocysteine levels and uterine artery Doppler for prediction of preeclampsia and isolated intrauterine growth restriction. Gynecol Obstet Invest 61 3 (2006) 142-148
85. Spencer K., Yu C.K., Savvidou M., et al. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation. Ultrasound Obstet Gynecol 27 6 (2006 Jun) 658-663
86. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 343 8898 (1994 Mar 12) 619-629
87. Duley L., Henderson-Smart D.J., Knight M., et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 1 (2004) CD004659
88. Askie L.M., Duley L., Henderson-Smart D.J., et al., on behalf of the PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia and its consequences: a systematic review and individual patient data meta-analysis. BMC Pregnancy Childbirth 5 7 (2005)
89. Goffinet F., Aboulker D., Paris-Llado J., et al. Screening with a uterine Doppler in low risk pregnant women followed by low dose aspirin in women with abnormal results: a multicenter randomised controlled trial. BJOG 108 5 (2001 May) 510-518
90. McCowan L.M., Harding J., Roberts A., et al. Administration of low-dose aspirin to mothers with small for gestational age fetuses and abnormal umbilical Doppler studies to increase birthweight: a randomised double-blind controlled trial. Br J Obstet Gynaecol 106 7 (1999 Jul) 647-651
91. Riyazi N., Leeda M., de Vries J.I., et al. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study. Eur J Obstet Gynecol Reprod Biol 80 1 (1998 Sep) 49-54
92. Kupferminc M.J., Fait G., Many A., et al. Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias. Hypertens Pregnancy 20 1 (2001) 35-44
93. North R.A., Ferrier C., Gamble G., et al. Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease. Aust N Z J Obstet Gynaecol 35 4 (1995 Nov) 357-362
94. Kupferminc M.J. Thrombophilia and pregnancy. Curr Pharm Des 11 6 (2005) 735-748
95. Chappell L.C., Seed P.T., Briley A.L., et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 354 9181 (1999 Sep 4) 810-816
96. Poston L., Briley A.L., Seed P.T., et al. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 367 (2006) 1145-1154
97. Rumbold A.R., Crowther C.A., Haslam R.R., et al. Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med 354 17 (2006 Apr 27) 1796-1806
98. Spinnato J.A., and Livingston J.C. Prevention of preeclampsia with antioxidants: evidence from randomized trials. Clin Obstet Gynecol 48 2 (2005 Jun) 416-429
99. Makrides M., Duley L., and Olsen S.F. Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. Cochrane Database Syst Rev 3 (2006) CD003402
100. Olsen S.F., Secher N.J., Tabor A., et al. Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team. BJOG 107 3 (2000 Mar) 382-395
101. Revello M.G., and Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 15 4 (2002 Oct) 680-715
102. Peyron F., Wallon M., Liou C., et al. Treatments for toxoplasmosis in pregnancy. Cochrane Database Syst Rev 2 (2000) CD001684
103. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 51 RR-6 (2002 May 10) 1-78
104. ACOG practice bulletin. Management of herpes in pregnancy. Number 8 October 1999. Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet 68 2 (2000 Feb) 165-173
105. Singh A.E., and Romanowski B. Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev 12 2 (1999 Apr) 187-209
106. Harding J.E., and Bloomfield F.H. Prenatal treatment of intrauterine growth restriction: lessons from the sheep model. Pediatr Endocrinol Rev 2 2 (2004 Dec) 182-192